Exchange: NYSE·Updated 03:06 PM EDT
News
all
press releases
Here's Why Labcorp Holdings (LH) is a Strong Momentum Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Zacks
More News
Labcorp Launches Next Generation of Labcorp Global Trial Connect to Help Sponsors and Investigator Sites Navigate Clinical Trial Complexity
Labcorp Launches Next Generation of Labcorp Global Trial Connect to Help Sponsors and Investigator Sites Navigate Clinical Trial Complexity Labcorp Launches Next Generation of Labcorp Global Trial Connect to Help Sponsors and Investigator Sites Navigate Clinical Trial Complexity PR Newswire...
PR Newswire
Labcorp to Speak at the Morgan Stanley 24th Annual Global Healthcare Conference
Labcorp to Speak at the Morgan Stanley 24th Annual Global Healthcare Conference Labcorp to Speak at the Morgan Stanley 24th Annual Global Healthcare Conference PR Newswire BURLINGTON, N.C., Aug. 28, 2026 BURLINGTON, N.C., Aug. 28, 2026 /PRNewswire/ -- Labcorp(NYSE: LH), a global leader of...
PR Newswire
Danaher Rides on Strength in Biotechnology Segment: Will It Sustain?
DHR's Biotechnology segment grows as China demand, bioprocessing and improving discovery markets offset regional headwinds.
Zacks
Should You Continue to Hold Labcorp Stock in Your Portfolio?
LH's specialty-testing expansion, strategic partnerships and buybacks support growth, while reimbursement and cost pressures pose risks.
Zacks
LH May 2027 Options Begin Trading
Investors in Labcorp Holdings Inc (Symbol: LH) saw new options begin trading today, for the May 2027 expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so with 270 days until expiration the newly trading contrac...
Nasdaq News: Markets
Labcorp to Offer First FDA-Cleared Blood Test to Detect Alzheimer's Disease Pathology in Both Primary and Specialty Care Settings
Labcorp to Offer First FDA-Cleared Blood Test to Detect Alzheimer's Disease Pathology in Both Primary and Specialty Care Settings Labcorp to Offer First FDA-Cleared Blood Test to Detect Alzheimer's Disease Pathology in Both Primary and Specialty Care Settings PR Newswire BURLINGTON, N.C., Aug. 24...
PR Newswire
IDXX Raises 2026 EPS Outlook as Diagnostic Growth and Margins Improve
IDEXX raises its 2026 EPS outlook as recurring diagnostics growth, wider margins and international expansion offset softer U.S. veterinary traffic.
Zacks
OPK Climbs 12.4% in the Past Month: Can the Stock Rally Keep Going?
OPKO Health's 12.4% monthly gain is backed by narrower losses and better margins, though profitability and clinical execution remain key risks.
Zacks
Labcorp and NACHC Launch Strategic Alliance to Strengthen Health Center Leadership and Advance Community Health
Labcorp and NACHC Launch Strategic Alliance to Strengthen Health Center Leadership and Advance Community Health Labcorp and NACHC Launch Strategic Alliance to Strengthen Health Center Leadership and Advance Community Health PR Newswire BURLINGTON, N.C. and BETHESDA, Md., Aug. 18, 2026 Collaboration...
PR Newswire

Advertisement|Remove ads.